Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Serum 25OHD3 shows positive associations with bone mineral density (BMD) at multiple femoral sites, whereas 25OHD2 shows generally negative associations at the same sites, and some of these do not reach statistical significance.

Source: Influence of Descriptive Granularity in Phenotype Data on Population Study Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants were excluded if the interval between the two measurement methods exceeded 2 h or if they were taking antihypertensive medications.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Towards a Compositional Framework for Describing Human Phenotypes

Study design awaiting verification · Advanced Science · 2026

Original publication title

Towards a Compositional Framework for Describing Human Phenotypes

Wanting Hu; Yunchao Ling; Xinyue Hu; Wei Chen; Rong Zhou; Xinhao Zhuang; Yanfeng Jiang; Jialu Zhao; Xingdong Chen; Jingchun Luo; Li Jin; Guoqing Zhang

© 2026 The Author(s). Advanced Science published by Wiley‐VCH GmbH

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

ABSTRACT

Deep phenotyping increasingly spans scales from macro to micro, yet heterogeneity in measurement and documentation still constrains standardization and limits comparability across cohorts. This study introduces a compositional framework that integrates the Phenotype Assembly Method (PhenoAM), Phenome Data Elements (PhenoDE), and a suite of large language model (LLM)‐based PhenoAgents to support systematic, interpretable, and scalable phenotype standardization with quality assessment. PhenoAM decomposes phenotype descriptions into features and qualifiers to enable component‐level mapping, while PhenoDE provides standardized representations of 58 371 phenotype data elements across 22 measurement platforms of the International Human Phenome Project (IHPP); pooled mapping coverage was 98.1% within the 18‐platform analysis set and 99.8% across all 22 platforms.

Using this representation, analyses of illustrative phenotypes from IHPP, National Health and Nutrition Examination Survey (NHANES), and the UK Biobank show that differences in features or qualifiers can influence data distributions and analytic outcomes, underscoring the importance of explicit measurement context in cross‐cohort studies. PhenoAgents support semantic parsing, terminology candidate retrieval, and data‐quality review through curator‐assisted modules. PhenoDEs and their statistical distributions within IHPP are accessible on the PhenoDE Portal.

Authors’ abstract

ABSTRACT

Deep phenotyping increasingly spans scales from macro to micro, yet heterogeneity in measurement and documentation still constrains standardization and limits comparability across cohorts. This study introduces a compositional framework that integrates the Phenotype Assembly Method (PhenoAM), Phenome Data Elements (PhenoDE), and a suite of large language model (LLM)‐based PhenoAgents to support systematic, interpretable, and scalable phenotype standardization with quality assessment. PhenoAM decomposes phenotype descriptions into features and qualifiers to enable component‐level mapping, while PhenoDE provides standardized representations of 58 371 phenotype data elements across 22 measurement platforms of the International Human Phenome Project (IHPP); pooled mapping coverage was 98.1% within the 18‐platform analysis set and 99.8% across all 22 platforms.

Using this representation, analyses of illustrative phenotypes from IHPP, National Health and Nutrition Examination Survey (NHANES), and the UK Biobank show that differences in features or qualifiers can influence data distributions and analytic outcomes, underscoring the importance of explicit measurement context in cross‐cohort studies. PhenoAgents support semantic parsing, terminology candidate retrieval, and data‐quality review through curator‐assisted modules. PhenoDEs and their statistical distributions within IHPP are accessible on the PhenoDE Portal.

Publication and source details

Original title: Towards a Compositional Framework for Describing Human Phenotypes

Wanting Hu; Yunchao Ling; Xinyue Hu; Wei Chen; Rong Zhou; Xinhao Zhuang; Yanfeng Jiang; Jialu Zhao; Xingdong Chen; Jingchun Luo; Li Jin; Guoqing Zhang

Advanced Science · 2026

© 2026 The Author(s). Advanced Science published by Wiley‐VCH GmbHhttps://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Noncommunicable Chronic Diseases‐National Science and Technology Major Project 2023ZD0510003 Shanghai Oriental Talents Program BJKJ2025055 Shanghai Science and Technology Innovation Action Plan 23JS1401500 Shanghai Municipal Science and Technology Major Project 2017SHZDZX012023SHZDZX02,GTP

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:39:35.595652+00:00

DOI: 10.1002/advs.77730 · PMC13598380